Missouri’s health department to begin enforcement action against food products containing unregulated psychoactive cannabis
Missouri’s Department of Health and Senior Services is on track to “embargo and condemn” products that contain intoxicating cannabinoids starting September 1, 2024 in accordance to an executive order signed by the state’s governor, Michael L. Parsons.
Copycat Life Savers product with psychoactive cannabis on left and the real Life Savers product on the right. Image courtesy of the Office of Governor Michael L. Parsons
Missouri’s Department of Health and Senior Services (DHSS) is on track to “embargo and condemn” products that contain intoxicating cannabinoids starting September 1, 2024 in accordance to an executive order signed by the state’s governor, Michael L. Parsons. Executive Order 24-10 was issued on August 1st, and pertains to “psychoactive cannabis products include delta-8 tetrahydrocannabinol (THC), delta-10 THC, hexahydrocannabinol (HHC), tetrahydrocannabinol (THC-O), tetrahydrocannabiphoral (THCP), tetrahydrocannabivarin (THCV), and other similar compounds.”
In addition to asking DHSS to “embargo and condemn unregulated psychoactive cannabis products,” the order also directed the Missouri Division of Alcohol and Tobacco Control (ATC) to amend its regulations to prohibit the sale of these products in liquor-licensed facilities. The state’s secretary of state Jay Ashcroft denied emergency rulemaking submitted by ATC in response to the executive order, but that will have no impact on the DHSS. ATC continues to pursue new rulemaking but will go through the regular channels which can take up to six to eight months.
Missouri’s DHSS states that there has been a 600% increase in the number of children ages five and under who have experienced cannabis poisoning that resulted in emergency room visits or hospitalizations since 2018. Many of these products are copycats of popular foods or candies such as Life Savers. This has been the case nationwide, with the U.S. Food and Drug Administration sending out warning letters to multiple brands selling copycat products containing intoxicating cannabinoids.
The provisions set forth in the executive order do not apply to products under the control of the Division of Cannabis Regulation under Article XIV of the Missouri Constitution.
Cannabis, US Presidential Election 2024, and Beyond: A Roundtable Discussion, Part II
December 17th 2024With the recent 2024 presidential election behind us, the future of cannabis still has many unknowns moving forward and questions still to be discussed. In this roundtable discussion with four knowledgeable industry leaders, we explore the nuanced political landscape of cannabis legalization and rescheduling in the context of the election, including state and federal policies and possible paths forward for testing standardization. Join us in the second part of a compilation of responses from Kim Anzarut, CQA, CP-FS, CEO of Allay Consulting; Susan Audino, PhD, founder of S.A. Audino & Associates, LLC; Zacariah Hildenbrand, PhD, research Professor at the University of Texas at El Paso; and David Vaillencourt, CEO of The GMP Collective.
Cannabis, US Presidential Election 2024, and Beyond: A Roundtable Discussion, Part I
December 16th 2024With the recent 2024 presidential election behind us, the future of cannabis still has many unknowns moving forward and questions still to be discussed. In this roundtable discussion with four knowledgeable industry leaders, we explore the nuanced political landscape of cannabis legalization and rescheduling in the context of the election. We discuss what drives support or opposition from both sides of the aisle, the complexities of balancing state and federal priorities, and more. Join us in the first part of a compilation of responses from Kim Anzarut, CQA, CP-FS, CEO of Allay Consulting; Susan Audino, PhD, founder of S.A. Audino & Associates, LLC; Zacariah Hildenbrand, PhD, research Professor at the University of Texas at El Paso; and David Vaillencourt, CEO of The GMP Collective.
Work Smarter, Not Harder: How ASTM Standards for Cannabinoids Improve Your Operations
December 3rd 2024ASTM Standards D8557-24 and D8556-24, provide unified guidelines for GMP (Good Manufacturing Practices) and QMS (Quality Management Systems) in cannabis operations. These standards enhance compliance, product safety, and operational consistency across the industry for the benefit of operators, consumers, and other stakeholders in the industry.
